Investigation on Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of a Long-acting GLP-1 Analogue (Semaglutide) in an Oral Formulation in Healthy Male Subjects

Clinical trial NCT01866748 · COMPLETED

Trial details

NCT number

NCT01866748

Sponsor

Novo Nordisk A/S

Status

COMPLETED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2013-05-01

Primary completion

2014-04-01

Enrollment

170

View on ClinicalTrials.gov